切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2016, Vol. 02 ›› Issue (03) : 167 -170. doi: 10.3877/cma.j.jssn.2096-1537.2016.03.006

所属专题: 重症医学 文献

专家论坛

肺部感染病原学流行病学的变迁给我们的提示
黎毅敏   
  • 收稿日期:2016-07-13 出版日期:2016-08-28
  • 通信作者: 黎毅敏

Changes in the epidemiology of pulmonary infections

Yimin Li   

  • Received:2016-07-13 Published:2016-08-28
  • Corresponding author: Yimin Li
  • About author:
    Corresponding author: Li Yimin, Email:
引用本文:

黎毅敏. 肺部感染病原学流行病学的变迁给我们的提示[J/OL]. 中华重症医学电子杂志, 2016, 02(03): 167-170.

Yimin Li. Changes in the epidemiology of pulmonary infections[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2016, 02(03): 167-170.

肺部感染性疾病是目前呼吸系统疾病的重点领域之一,其中,呼吸机相关性肺炎(Ventilator associated pneumonia,VAP)是导致ICU住院天数延长及病死率升高的主要疾病之一。随着个人及公共卫生环境的变化,细菌耐药株的增多和易感人群的扩大,肺部感染病原学流行病学在近年来发生了较大的变迁,耐药率及难治性病例也随之增多。病原学流行病学改变,无疑为我们ICU临床工作增加了障碍,但同时也提示了现有的肺部感染临床诊疗存在的不足之处,我们仍需加强早期感染防控,早期诊断治疗及抗生素规范化治疗。

Pulmonary infectious disease is one of the main type of the respiratory system disease. Ventilator associated pneumonia(VAP) is a major cause for prolonged hospitalization days and higher mortality in ICU. However, Along with changes in personal and public health environment, as well as the increase of drug-resistant bacteria and the expansion of the susceptible population, a large transition has occurred in the epidemiology of pulmonary infectious disease in recent years. This alteration has undoubtedly made clinical work in ICU more difficult, whereas brings up hints on diagnosis and treatment for pulmonary infectious diseases and also suggests our limitations in prevention, diagnosis and anti-infection treatment.

[1]
Zhang Y, Zhang F, Wang H, et al. Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from community-acquired respiratory tract infections in China: Results from the CARTIPS Antimicrobial Surveillance Program[J]. J Glob Antimicrob Resist, 2016, 5:36–41.
[2]
唐贞明. 医院与社区获得性肺炎的病原菌分布及耐药性[J]. 中华医院感染学杂志, 2014, 24(5):1092–1094.
[3]
Xie DS, Xiong W, Xiang LL, et al. Point prevalence surveys of healthcare-associated infection in 13 hospitals in Hubei Province, China, 2007-2008[J]. J Hosp Infect, 2010, 76(2):150–155.
[4]
Barbier F, Andremont A, Wolff M, et al. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management[J]. Curr Opin Pulm Med, 2013, 19(3):216–228.
[5]
Bos LD, Martin-Loeches I, Kastelijn JB, et al. The volatile metabolic fingerprint & of ventilator-associated pneumonia[J]. Intensive Care Med, 2014, 40(5):761–762.
[6]
Shaw AG, Vento TJ, Mende K, et al. Detection of methicillin-resistant and methicillin-susceptible Staphylococcus aureus colonization of healthy military personnel by traditional culture, PCR, and mass spectrometry[J]. Scand J Infect Dis, 2013, 45(10):752–759.
[7]
Pugh R, Grant C, Cooke RP, et al. Short-course versus prolonged-course antibiotic therapy for hospital-acquired pneumonia in critically ill adults[J]. Cochrane Database Syst Rev, 2015, (8):CD007577.
[8]
Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012[J]. Intensive Care Med, 2013, 39(2):165–228.
[9]
Zagli G, Cozzolino M, Terreni A, et al. Diagnosis of ventilator-associated pneumonia: a pilot, exploratory analysis of a new score based on procalcitonin and chest echography[J]. Chest, 2014, 146(6):1578–1585.
[10]
Livermore DM, Warner M, Mushtaq S. Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa[J]. J Antimicrob Chemother, 2013, 68(10):2286–2290.
[11]
Palmer LB, Smaldone GC. Reduction of bacterial resistance with inhaled antibiotics in the intensive care unit[J]. Am J Respir Crit Care Med, 2014, 189(10):1225–1233.
[12]
Imberti R, Cusato M, Villani P, et al. Steady-state pharmacokinetics and BAL concentration of colistin in critically ill patients after Ⅳ colistin methanesulfonate administration[J]. Chest, 2010, 138(6):1333–1339.
[13]
Gautret P, Gray GC, Charrel RN, et al. Emerging viral respiratory tract infections-environmental risk factors and transmission[J]. Lancet Infect Dis, 2014, 14(11):1113–1122.
[14]
Feng WL, Yang J, Xi ZQ, et al. Epidemiologic study on patients with invasive fungal infections[J]. Zhonghua Liu Xing Bing Xue Za Zhi, 2009, 30(10):1043–1046.
[15]
Pascual A, Calandra T, Bolay S, et al. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes[J]. Clin Infect Dis, 2008, 46(2):201–211.
[16]
Hamet M, Pavon A, Dalle F, et al. Candida spp. Airway colonization could promote antibiotic-resistant bacteria selection in patients with suspected ventilator-associated pneumonia[J]. Intensive Care Med, 2012, 38(8):1272–1279.
[17]
Xu H, Li L, Huang WJ, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: a case control study from China[J]. Clin Microbiol Infect, 2012, 18(4):403–408.
[18]
Fang W, Fa Z, Liao W. Epidemiology of Cryptococcus and cryptococcosis in China[J]. Fungal Genet Biol, 2015, 78:7–15.
[19]
Hsu LY, Lee DG, Yeh SP. Epidemiology of invasive fungal diseases among patients with haematological disorders in the Asia-Pacific: a prospective observational study[J]. Clin Microbiol Infect, 2015, 21(6):594.e7–11.
[1] 农云洁, 黄小桂, 黄裕兰, 农恒荣. 超声在多重肺部感染诊断中的临床应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 872-876.
[2] 刘欢, 邢皓, 常正奇, 张记. 机械敏感性离子通道蛋白Piezo1在感染相关疾病中的研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 263-269.
[3] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[4] 陈浩, 王萌. 胃印戒细胞癌的临床病理特征及治疗选择的研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 108-111.
[5] 梁孟杰, 朱欢欢, 王行舟, 江航, 艾世超, 孙锋, 宋鹏, 王萌, 刘颂, 夏雪峰, 杜峻峰, 傅双, 陆晓峰, 沈晓菲, 管文贤. 联合免疫治疗的胃癌转化治疗患者预后及术后并发症分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 619-623.
[6] 许月芳, 刘旺, 曾妙甜, 郭宇姝. 多粘菌素B和多粘菌素E治疗外科多重耐药菌感染临床疗效及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 700-703.
[7] 皮尔地瓦斯·麦麦提玉素甫, 李慧灵, 艾克拜尔·艾力, 李赞林, 王志, 克力木·阿不都热依木. 生物补片修补巨大复发性腹壁切口疝临床疗效分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 624-628.
[8] 顾熙, 徐子宇, 周澍, 张吴楼, 张业鹏, 林昊, 刘宗航, 嵇振岭, 郑立锋. 腹股沟疝腹膜前间隙无张力修补术后补片感染10 例报道[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 665-669.
[9] 臧宇, 姚胜, 朱新勇, 戎世捧, 田智超. 低温等离子射频消融治疗腹壁疝术后补片感染的临床效果[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 687-692.
[10] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[11] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[12] 王涛, 刘静, 高玉伟, 王兴华, 胡秀红, 崔红蕊, 徐保振, 杨洪娟. 抗生素耐药背景下中医药防治腹膜透析相关性腹膜炎研究进展[J/OL]. 中华肾病研究电子杂志, 2024, 13(06): 340-344.
[13] 贾玲玲, 滕飞, 常键, 黄福, 刘剑萍. 心肺康复在各种疾病中应用的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 859-862.
[14] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[15] 徐靖亭, 孔璐. PARP抑制剂治疗卵巢癌的耐药机制及应对策略[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 584-588.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?